Category: Epidarex

October, 2014 – Epidarex is a specialist life science venture capital group that recently raised a new fund of £47.5 million dedicated to UK start

Epidarex Capital, a leading international venture capital firm, has raised over £47.5 million to lead investments in early-stage life science and health technology companies, including

Edinburgh, United Kingdom – January 21st 2013 – Rock Spring Ventures today launched a unique £50m venture capital fund focusing on early-stage life science and